Effects of Intravenous Bendavia™ on Reperfusion Injury in Patients Undergoing Angioplasty of the Renal Artery

NCT01755858 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

16

Enrollment

INDUSTRY

Sponsor class

Conditions

Renal Artery Obstruction
Hypertension, Renovascular
Ischemia Reperfusion Injury

Interventions

DRUG: Bendavia
DRUG: Placebo

Sponsor

Stealth BioTherapeutics Inc.